Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs ElitePhysiqMD

Claya
Graded #264

Lower grade

vs+5
ElitePhysiqMD
Graded #154

Higher grade

The verdict

ElitePhysiqMD takes it — 67.8/100 to 62.8/100.

ElitePhysiqMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElitePhysiqMD is a physician-led telehealth platform prescribing compounded semaglutide (from $145/mo) and tirzepatide (from $315/mo subscription) to patients in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElitePhysiqMD +33
42
75
Dose & formulationClaya +11
75
64
Clinical oversightClaya +3
82
79
Labs & monitoringClaya +1
53
52
FulfillmentElitePhysiqMD +2
67
69
Contract termsClaya +6
61
55
Claya · left barElitePhysiqMD · right bar

The numbers

MetricClayaElitePhysiqMD
WeighScore62.8/10067.8/100
GradeCC
Scorecard rank#264#154
Semaglutide$299/mo (compounded)$145/mo (starting dose, compounded)
Tirzepatide$299/mo (compounded)$315/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
ElitePhysiqMD

Graded #154 · C

Strengths

  • Compounded semaglutide from $145/mo subscription with no video calls and cancel-anytime policy
  • LegitScript certified, HIPAA-compliant; prescriptions from board-certified physicians via 5-min online assessment
  • Medications from US-licensed 503A/503B compounding pharmacies, shipped discreetly in 5–7 business days
  • HSA/FSA eligible; accepts all 50 states with no insurance required
  • Peptide therapy also available: NAD+, sermorelin, CJC-1295/ipamorelin, GHK-Cu, and glutathione

Where it loses points

  • Required $49 telehealth visit is added to every order, increasing effective monthly cost above the headline price
  • No labs disclosed; medication plans don't appear to include bloodwork or baseline testing
  • No dietitian, coaching, or nutrition support mentioned; program is medication-only
  • Tirzepatide subscription price ($315/mo) is above the mid-range for compounded tirzepatide
  • Newer platform (founded late 2025); no Trustpilot rating or public patient reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard